Mucosolvan Injection Action

Mucosolvan Injection, also known as Ambroxol Hydrochloride Injection, is a prescription medication with expectorant and antitussive effects. Its main active ingredient is ambroxol, which belongs to the class of mucolytic agents. It effectively relieves coughing and improves the viscosity of sputum by promoting increased secretion from bronchial glands.

Specifically, ambroxol in Mucosolvan reduces the intermolecular binding forces of mucoproteins, making sputum thinner and easier to expel. This is particularly effective for patients experiencing viscous sputum and difficulty expectorating. Additionally, ambroxol hydrochloride in the medication stimulates the cough center and increases respiratory tract secretion, thus helping patients expel sputum more effectively. Clinically, Mucosolvan Injection is primarily used in the treatment of patients with difficult coughing and expectoration associated with acute and chronic bronchitis, bronchial asthma, bronchiectasis, emphysema, and pulmonary tuberculosis. Mucosolvan achieves a bronchodilatory effect by inhibiting adenylate cyclase activity and reducing intracellular cAMP levels, thereby relieving dyspnea caused by asthma or other respiratory diseases.

During use, follow the doctor's instructions and monitor for adverse reactions such as stomach pain. Appropriate measures should be taken when necessary.